Clinical Trial Update: myDC/pDC in Stage III Melanoma Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update on myDC/pDC therapy in Stage III melanoma patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• myDC/pDC

Snippet

Sponsor: Radboud University Medical Center | Conditions: Melanoma | Phase 1, Phase 2 | Status: COMPLETED